Chuanyu Yu, Xueyan Liu, Bingxiang Ma, Jiexin Xu, Yiquan Chen, Chaoxian Dai, . . . Daijun Zha. (2024). Novel anti-neuroinflammatory pyranone-carbamate derivatives as selective butyrylcholinesterase inhibitors for treating Alzheimer's disease. Taylor & Francis Group.
Chicago Style (17th ed.) CitationChuanyu Yu, Xueyan Liu, Bingxiang Ma, Jiexin Xu, Yiquan Chen, Chaoxian Dai, Huaping Peng, and Daijun Zha. Novel Anti-neuroinflammatory Pyranone-carbamate Derivatives as Selective Butyrylcholinesterase Inhibitors for Treating Alzheimer's Disease. Taylor & Francis Group, 2024.
MLA (9th ed.) CitationChuanyu Yu, et al. Novel Anti-neuroinflammatory Pyranone-carbamate Derivatives as Selective Butyrylcholinesterase Inhibitors for Treating Alzheimer's Disease. Taylor & Francis Group, 2024.